Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis.
Serratrice
J
J
Service de Médecine Interne, CHU Timone, Marseille, France.
Granel
B
B
Swiader
L
L
Disdier
P
P
De Roux-Serratrice
C
C
Raccah
D
D
Weiller
P J
PJ
D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003622:Dapsone / Q000627:therapeutic use*; D004906:Erythrocyte Count; D005215:Fasting; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism*; D006461:Hemolysis; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D011081:Polychondritis, Relapsing / Q000097:blood / Q000150:complications*
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D003622:Dapsone; D006442:Glycated Hemoglobin